Literature DB >> 6169548

Hepatocyte targeting of adenine-9-beta-D-arabinofuranoside 5' -monophosphate (ara-AMP) coupled to lactosaminated albumin.

L Fiume, C Busi, A Mattioli, P G Balboni, G Barbanti-Brodano.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6169548     DOI： 10.1016/0014-5793(81)80179-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  3 in total

Review 1.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

2.  A study on the pharmacokinetics in mouse of adenine-9-beta-D-arabinofuranoside 5-monophosphate conjugated with lactosaminated albumin.

Authors:  L Fiume; B Bassi; C Busi; A Mattioli; T Wieland
Journal:  Experientia       Date:  1985-10-15

3.  Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver.

Authors:  L Fiume; A Mattioli; C Busi; C Accorsi
Journal:  Gut       Date:  1984-12       Impact factor: 23.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.